REGEN BIOPHARMA, INC. Derivative Liability, Current
REGEN BIOPHARMA, INC. (RGBP) had Derivative Liability, Current of $1.40 million as of 2024-09-30, per its 8-K filed 2024-11-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2024-11-29
- 2024-09-30: Derivative Liability, Current $1.40M.
| Period end | Derivative Liability, Current |
|---|---|
| 2024-09-30 | $1.40M 8-K · filed 2024-11-29 |